Cargando…
Osteoprotegerin rich tumor microenvironment: implications in breast cancer
Osteoprotegerin (OPG) is a soluble decoy receptor for tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL). It belongs to the tumor necrosis factor receptor superfamily (TNFRSF). OPG was initially discovered to contribute to homeostasis of bone turnover due to its capability of bind...
Autores principales: | Goswami, Sudeshna, Sharma-Walia, Neelam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173171/ https://www.ncbi.nlm.nih.gov/pubmed/27072583 http://dx.doi.org/10.18632/oncotarget.8658 |
Ejemplares similares
-
Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis
por: Goswami, Sudeshna, et al.
Publicado: (2016) -
Osteoprotegerin secreted by inflammatory and invasive breast cancer cells induces aneuploidy, cell proliferation and angiogenesis
por: Goswami, Sudeshna, et al.
Publicado: (2015) -
Implications of a peroxisome proliferator-activated receptor alpha (PPARα) ligand clofibrate in breast cancer
por: Chandran, Karthic, et al.
Publicado: (2015) -
Therapeutic implications of osteoprotegerin
por: Fili, Sofia, et al.
Publicado: (2009) -
Virus and tumor microenvironment induced ER stress and unfolded protein response: from complexity to therapeutics
por: Asha, Kumari, et al.
Publicado: (2018)